Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASR cardiovascular fixed-dose combination pill pharmacodynamic LDL study
2010-019720-32Phase 2Terminated
- Sponsor
- Ferrer
- Start
- May 2010
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of aspirin, simvastatin and ramipril in Cardiovascular disease (CVD) (2 arms), sponsored by Ferrer. Primary endpoint: LDL cholesterol pharmacodynamic effect. Started May 2010; status: terminated.
02
Drugs
aspirinsimvastatinramipril
03
Conditions
Cardiovascular disease (CVD)
Beyond the preview
Go deeper on 2010-019720-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019720-32.